- Home
- ZDGE vs LVTX Comparison
ZDGE vs LVTX Comparison
Compare ZDGE & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- LVTX
- Stock Information
- Founded
- ZDGE 2008
- LVTX 2016
- Country
- ZDGE United States
- LVTX Netherlands
- Employees
- ZDGE N/A
- LVTX N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- LVTX Health Care
- Exchange
- ZDGE Nasdaq
- LVTX Nasdaq
- Market Cap
- ZDGE 40.3M
- LVTX 33.9M
- IPO Year
- ZDGE N/A
- LVTX 2021
- Fundamental
- Price
- ZDGE $3.81
- LVTX $1.37
- Analyst Decision
- ZDGE
- LVTX Hold
- Analyst Count
- ZDGE 0
- LVTX 3
- Target Price
- ZDGE N/A
- LVTX $1.75
- AVG Volume (30 Days)
- ZDGE 419.5K
- LVTX 10.4K
- Earning Date
- ZDGE 06-12-2025
- LVTX 08-19-2025
- Dividend Yield
- ZDGE N/A
- LVTX N/A
- EPS Growth
- ZDGE N/A
- LVTX N/A
- EPS
- ZDGE N/A
- LVTX N/A
- Revenue
- ZDGE $29,511,000.00
- LVTX $4,990,000.00
- Revenue This Year
- ZDGE N/A
- LVTX N/A
- Revenue Next Year
- ZDGE $1.07
- LVTX N/A
- P/E Ratio
- ZDGE N/A
- LVTX N/A
- Revenue Growth
- ZDGE 1.27
- LVTX N/A
- 52 Week Low
- ZDGE $1.73
- LVTX $0.85
- 52 Week High
- ZDGE $4.38
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- ZDGE 58.35
- LVTX 60.82
- Support Level
- ZDGE $3.88
- LVTX $1.27
- Resistance Level
- ZDGE $4.30
- LVTX $1.40
- Average True Range (ATR)
- ZDGE 0.24
- LVTX 0.05
- MACD
- ZDGE -0.06
- LVTX 0.00
- Stochastic Oscillator
- ZDGE 18.05
- LVTX 73.08
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.